Integrating PrEP Into Mobile Addiction Treatment and Primary Care Services
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 4
SUMMARY
For this study the investigators aim to see if giving participants an oral HIV prevention medication on a medical van, is a good option of care for individuals who inject drugs and/or are sexually active and therefore at a higher risk of contracting HIV.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:
• 18 years or older, active drug injection user and/or sexually active, referred from the Syringe Service Program
Locations
United States
North Carolina
Duke Department of Population Health Sciences
RECRUITING
Durham
Contact Information
Primary
Amelia R Ashkin-Baker, BA
amelia.ashkin-baker@duke.edu
(919)448-8680
Backup
Madelene Travis, BA
madelene.travis@duke.edu
Time Frame
Start Date: 2025-09-17
Estimated Completion Date: 2026-07-31
Participants
Target number of participants: 20
Treatments
Experimental: PrEP
All eligible participants will be given oral PrEP pills to reduce their risk for contracting HIV.
Related Therapeutic Areas
Sponsors
Collaborators: National Institute of Allergy and Infectious Diseases (NIAID)
Leads: Duke University